Pharma Manufacturing’s Post

🧬 Biotechnology is a Critical Technology: Roadmap to a Globally Competitive and Resilient EU #Biotech plays a critical role in shaping the EU’s future. The need for policies that support the global development of biotech innovation to benefit economies, societies, and citizens is clear. As #EU Leaders meet to agree on the EU strategic agenda, we need comprehensive and coordinated actions to foster visibility, recognition and delivery for biotech #innovation that can deliver a globally competitive, sustainable, and resilient EU. Read our recommendations below ➡️ And discover our roadmap at: https://lnkd.in/ePf33hbu

📣 New targeted actions to boost biotechnology and biomanufacturing in the EU! The Communication on Building the future with nature identifies the challenges and barriers and proposes to tackle them, in line with the Communication on the long-term competitiveness of the EU. The Communication also highlights #intellectualproperty as a critical asset, especially for emerging biotech companies to secure financing, and pleads for a "more integrated approach to the technology transfer process in the Member States". Read more 👉 https://lnkd.in/e_rVVip9 #biotechnology #biomanufacturing

🍀 Exciting news for biotech! 🍀 The Commission has announced a comprehensive initiative aimed at addressing the challenges facing biotechnology and biomanufacturing. From enhancing research and facilitating the transfer of technology to the market to simplifying regulatory complexities and improving access to finance, these actions are designed to foster growth, innovation, and sustainability. ⏩ https://lnkd.in/eeFpbNNc  We look forward to leveraging these new initiatives to accelerate our projects. Stay tuned for updates on how we're advancing our contributions to biotech. #FibriTech #EUeic #eicAccelerator #Biotechnology #Biomanufacturing #Innovation #Sustainability

🧬 Biotechnology is a Critical Technology: Roadmap to a Globally Competitive and Resilient EU European institutions are looking toward the agenda of the next five years. Now is the time for EU policymakers to recognize the value of #biotech innovation for EU competitiveness and resilience. We need a coordinated #EU approach to access capital and finance to create, scale-up, and grow biotech companies into global leaders. Read below EuropaBio - the European Association for Bioindustries’s recommendations. And discover our roadmap at: https://lnkd.in/ePf33hbu

What do the topics of omics and advanced therapies, capital attraction, complex manufacturing and medtech have in common? They are all key themes in the latest edition of Australasian BioTechnology, the official journal of AusBiotech, that we encourage everyone to read via the link below. Of note is the article, “Strategic Financing: Alternative Funding Models in Biotechnology”, which provides some valuable insights on how to secure project support in a tough economic environment. Alithia is also proud to have a presence in this issue, as it delivers a great opportunity to raise awareness of the specialist services we can offer, as well as foster new connections within the industry. Read here: https://lnkd.in/ggBqEdZ7 #biotech #biotechnologyindustry #industrynews #funding #financing Image credit: Executive Media Pty Ltd

Rigorous Due Diligence for Alternative Protein, Fermentation, and Bioenergy Investments At Stealth Bioenergy and Biotechnology Consulting, our 200+ SMEs recognize that institutional investors require in-depth techno-economic analysis before deploying capital into emerging biotech sectors like alternative proteins and bioenergy. Our proven project evaluation framework includes: 1. Signing NDAs to protect sensitive information on novel technologies and processes. Discretion is key when conducting due diligence. 2. Thorough data collection on production projections, operational expenditures, capital costs, target markets and competing solutions. We leave no stone unturned. 3. Rigorous financial modeling using dynamic variables to assess production economics, ROI potential, sensitivity analysis and risk factors. 4. Benchmarking key performance metrics like production yields, operating costs and product margins versus incumbent solutions and competing startups. 5. Checking claims against scientific fundamentals and commercial feasibility. We validate what's real versus hype. 6. Evaluating market dynamics, regulatory constraints, adoption barriers and supply chain maturity. The market landscape is analyzed in-depth. 7. Providing clear recommendations on investment merit and risk-return profile compared to alternatives. You get our unbiased assessment. If you are conducting diligence in the precision fermentation or bioenergy markets, leverage our technical expertise and commercial rigor of our 200+ subject matter experts (top tier PhDs and C-suite execs). We distill complex data into actionable insights on value creation opportunities. Partner with us to make informed investment decisions. #investing #TEA #bioenergy #biotechnology #alternativeproteins #fermentation rg@stealthbb.com www.stealthbb.com

Seeing a convergence of lifesaving technologies to address food insecurity, and sustainable global health accross our companies at bioMérieux, INSTITUT MÉRIEUX, Mérieux Développement SAS, Mérieux Université and Transgene

Last year, biotech was designated a critical technology by the EU, marking a massive step towards the European sector's goal of becoming a global leader. How can we maintain this momentum? This article from EuropaBio has some sound suggestions. What stuck out to me most was their call for a holistic approach to legislation. Piecemeal legislation isn't exactly conducive to an attractive R&D environment and creates a reactive regulatory system. Taking a holistic approach is key to helping the sector mature and grow. #Biotechnology #Innovation #Criticaltechnology #BiotechLegislation

🌍 Biotechnology is shaping the future—but trust is key! 🌱 #Biotech is transforming industries across Europe, but there’s a challenge: only 53% of Europeans #trust it. Without trust, #innovation slows, and progress stalls. How can we change this? Join us on October 8th at 9:00 CET for the #BTrust #Masterclass to explore how #consumer acceptance is driving innovation in #agrifood and #biobased biotechnology. Featuring insights from: 🔸 Prof. Jessica Aschemann-Witzel (Aarhus University) 🔸 Dr. Laurien Van Dyck (VIB) 🔸 Anna De Cock (Dudkiewicz) (Paleo) 🔸 Veerle Rijckaert and Charlotte Boone (Alice down the rabbit hole) This is your chance to understand how trust is built and why it matters for the future of biotech. 🌱 🔗 Learn more & register: https://lnkd.in/dWgtkPtQ This project is funded by the European Union's Horizon Europe programme 2021-2027.

Sustainable, clean and totally craveable, 👉🌭👈 our future-proof proteins have it all! But how will the consumer be swayed? 🤔 🙋♀️ Join our very own Anna De Cock (Dudkiewicz) tomorrow at 9 AM during Flanders' FOOD & B-Trust's webinar for a B2B perspective on bridging the #technology #trust gap. 🥩 As we're helping #plantbased food manufacturers to create the meat & fish alternatives that consumers crave, we care for their concerns. 💡 Discover how Paleo is deepening its understanding and tackling the barriers to #altprotein adoption through co-creation with both customers and end-consumers. #SameTaste #DifferentStory